Dr. Amir S. Lotfi, MD

Dr. Lotfi practices at Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health.

Dr. Lotfi's NPI, 1790714400, was assigned on July 3, 2006. Dr. Lotfi holds Massachusetts license 213778.

Dr. Lotfi's primary practice is Baystate Medical Center, at 759 Chestnut Street, Springfield, MA 01199 in Hampden County. The practice phone is (413) 794-0000.

Dr. Lotfi's primary practice is Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health. Dr. Lotfi is also affiliated with Cooley Dickinson Hospital. The medical group on file is Baystate Medical Practices. Dmand AI also links Dr. Lotfi to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lotfi practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Lotfi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Lotfi is licensed in Massachusetts.

CMS data shows 1,016 Medicare services from Dr. Lotfi across 16 procedure codes in 2024, for 685 Medicare patients. Medicare paid $87,702 for them.

CMS counts 685 Medicare patients who saw Dr. Lotfi in 2024. The largest group is 75 to 84, with 270 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lotfi's median patient age at 74, with 40% women.

In 2024, Dr. Lotfi wrote 1,646 Medicare Part D claims for 259 patients. 85% of them were for generic drugs. CMS names the drug for 1,456 of them, across 23 drugs with 11 or more claims each, at $193,432 in total drug cost. In 2023, CMS named 1,494 claims across 21 drugs.

Dr. Lotfi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lotfi as offering telehealth. CMS counts 18 procedures of coronary angioplasty and stenting by Dr. Lotfi, more than 46% of the clinicians it reports for that procedure.

Dmand AI links 90 papers to Dr. Lotfi, published from 2011 to 2025. 2017 was the busiest year, with 7. The most frequent topics are Percutaneous Coronary Intervention, Coronary Artery Disease and Coronary Angiography. Dr. Lotfi has published most often in Crit Pathw Cardiol. Dr. Lotfi's most frequent co-authors are Gregory R. Giugliano, MD, Alawi A. Alsheikh-Ali, MD and Lloyd W. Klein, MD.

Dmand AI links Dr. Lotfi to 4 clinical trials. 1 is still active or recruiting. Conditions studied include ST Elevation Myocardial Infarction, Myocardial Infarction and Hematoma, Subdural. TherOx sponsors the most, 2. Open Payments lists research payments to Dr. Lotfi that name 3 trials.

CMS Open Payments shows 153 general payments to Dr. Lotfi from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Medtronic, Inc. paid the most, $10,509. It also lists 7 research payments totaling $50,750 from 2019 to 2022, naming 3 clinical trials.